{"id":"W4412492282","doi":"10.1007/s13555-025-01463-6","title":"Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta; University of Saskatchewan; EVERSANA (Canada); Western University; University of Toronto; Dalhousie University; Dermatrials Research; Probity Medical Research; McMaster University","funders":"LEO Pharma; Bausch Health; Astellas Pharma; Mylan; Incyte; Dermira; Sun Pharma; Regeneron Pharmaceuticals; Celgene; Valeant Pharmaceuticals International; Janssen Canada; Sanofi; Amgen; Pfizer; Meiji Seika Pharma; Galderma; Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Psoriasis Area and Severity Index; Secukinumab; Internal medicine; Onset of action; Psoriasis; Confidence interval; Meta-analysis; Dermatology; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01815327,0.002731207,0.01848891,0.00875851,0.0005486578,0.003213437,0.001995972,0.001923095,0.004302214],"category_scores_gemma":[0.03664519,0.001344206,0.03814527,0.009514951,0.0006517603,0.002188319,0.002013772,0.002005293,0.0003986664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003201692,"about_ca_system_score_gemma":0.0041136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007431822,"about_ca_topic_score_gemma":0.01599472,"domain_scores_codex":[0.9877359,0.006318257,0.002831698,0.00138435,0.001365555,0.0003642026],"domain_scores_gemma":[0.9740618,0.01906756,0.004033883,0.0007108949,0.001787641,0.0003381846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002069529,0.00002512977,0.002616286,0.3210511,0.6628807,0.0001068579,0.00006255561,0.0008013592,0.0001626161,0.0001792567,0.0006446285,0.009400091],"study_design_scores_gemma":[0.000572973,0.000133729,0.00211935,0.01856943,0.9766001,0.00006735446,0.00002708532,0.0002741869,0.00006806514,0.0002430049,0.001304515,0.00002026616],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005787571,0.9903319,0.001262621,0.0002933251,0.0001828248,0.0005855455,0.001087854,0.00005110125,0.0004173566],"genre_scores_gemma":[0.2286983,0.7602833,0.004064941,0.001391288,0.0003315211,0.002657782,0.001922565,0.00006911111,0.0005811814],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01848891,"threshold_uncertainty_score":0.09600478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03194058658706835,"score_gpt":0.2905279435827251,"score_spread":0.2585873569956568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}